|
|
Volumn 114, Issue 1, 1999, Pages 3-11
|
|
Development of σ-receptor ligands and clinical trials
|
|
Author keywords
Antipsychotic; Anxiolytic; Neuroprotective; Nootropic; receptors
|
|
Indexed keywords
1 (3 CHLORO 4 CYCLOHEXYLPHENYL) 3 (HEXAHYDRO 1 AZEPINYL)PROPENE;
1 CYCLOPROPYLMETHYL 4 [2 (4 FLUOROPHENYL) 2 OXOETHYL]PIPERIDINE;
2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE;
4 (4 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 [4 (1,2,4 TRIAZOL 1 YL)BUTYL]PYRIDINE;
6 [6 (4 HYDROXY 1 PIPERIDINYL)HEXYLOXY] 3 METHYLFLAVONE;
ACN 111;
AH 9700;
ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL;
CINUPERONE;
CNS 1044;
CNS 1307;
CNS 3040;
EMD 56551;
FH 510;
FI 8300;
IGMESINE;
KB 5492;
LANICEMINE;
LU 28 179;
LU 29252;
MS 257;
MS 355;
MS 377;
N ALLYLNORMETAZOCINE;
N CYCLOHEXYL N ETHYL 3 (3 CHLORO 4 CYCLOHEXYLPHENYL) 2 PROPENYLAMINE;
N,N DIMETHYLPHENETHYLAMINE;
NPC 16316;
OPC 14523;
PANAMESINE;
PD 144418;
SIGMA RECEPTOR LIGAND;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
AMINO ACID SEQUENCE;
ANXIETY;
COUGHING;
DEMENTIA;
DEPRESSION;
DIARRHEA;
DRUG ABUSE;
DRUG INDICATION;
EPILEPSY;
INFLAMMATION;
MICTURITION DISORDER;
NEUROPROTECTION;
PSYCHOPHARMACOLOGY;
PSYCHOSIS;
RECEPTOR INTRINSIC ACTIVITY;
REVIEW;
SEQUENCE HOMOLOGY;
|
|
EID: 0032778430
PISSN: 00155691
EISSN: None
Source Type: Journal
DOI: 10.1254/fpj.114.3 Document Type: Review |
|
Times cited : (1)
|
|
References (84)
|
